JacquelineCBarrientosMDMS
Hematology • Miami Beach, FLHematologic Oncology
Adjunct Professor, Medicine, Zucker School of Medicine
Dr. Barrientos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4306 Alton Rd 3rd floor
Miami Beach, FL 33140Phone+1 305-535-3300- Is this information wrong?
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2006 - 2009
Yale-New Haven Medical CenterResidency, Internal Medicine, 2002 - 2005
Ponce Health Sciences University School of MedicineClass of 2001
Certifications & Licensure
FL State Medical License 2022 - 2026
NY State Medical License 2006 - 2023
CT State Medical License 2005 - 2012
Clinical Trials
- A Phase I Study of GNKG168 in Patient With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL) Start of enrollment: 2009 Sep 01
- Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Relapsed/Refractory Marginal Zone Lymphoma Start of enrollment: 2013 Dec 01
- Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Start of enrollment: 2014 Feb 20
- Join now to see all
Publications & Presentations
PubMed
- MRD-directed therapy in CLL: ready for prime time?Rhodes, J., Lopez, C., Barrientos, J.> ;Hematology. American Society of Hematology. Education Program. 2023 Dec 8
- Results from a Real-World Multicenter Analysis of 482 Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Look at Racial Differences.Jacqueline C Barrientos, Ayed O Ayed, Agnes Cha, Senxi Du, Bruno Fang, Ryan Hall, Stanley M Marks, Eileen Peng, Joanna M Rhodes, Kellie Ryan, Sharon B Winters, Percy L...> ;Targeted Oncology. 2023 Sep 1
- 1 citationsCharacteristics and Clinical Outcomes of Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receiving Ibrutinib for ≥5 Years in the RESONATE-2 Study.Jennifer A Woyach, Paul M Barr, Thomas J Kipps, Jacqueline C Barrientos, Inhye E Ahn, Paolo Ghia, Vincent Girardi, Emily Hsu, Mandy Jermain, Jan A Burger> ;Cancers. 2023 Jan 13
- Join now to see all
Abstracts/Posters
- Cirmtuzumab, a ROR1 Targeted Mab, Reverses Cancer Stemness, and Its Combination with Ibrutinib Is Safe and Effective: Planned Analysis of the Cirll Phase 1/2 Trial for...Jacqueline C. Barrientos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Efficacy of Therapies Following Venetoclax Discontinuation in CLL: Focus on B-Cell Receptor Signal Transduction Inhibitors and Cellular TherapiesJacqueline C Barrientos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Cirmtuzumab, a ROR1 Targeted Mab, Reverses Cancer Stemness, and Its Combination with Ibrutinib Is Safe and Effective: Planned Analysis of the Cirll Phase 1/2 Trial for...Jacqueline C. Barrientos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- Defined Duration Frontline Chemoimmunotherapy in Chronic Lymphocytic Leukemia: Less Is MoreASCO Annual Meeting 2019 - Chicago, IL - 6/4/2019
- Extended Survival in CLL Patients Who Discontinued Idelalisib Because of Colitis Correlates with Higher Th17 Levels in Blood and Colon Tissue2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Ibrutinib Treatment Reduces Myeloid Derived Suppressor Cell Numbers and Function in Chronic Lymphocytic Leukemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
Managing Chronic Lymphocytic Leukemia in 2020: An Update on Recent Clinical Advances with a Focus on BTK and BCL-2 InhibitorsFebruary 26th, 2021
Study of Ibrutinib in CLL Shows a Benefit, but Raises Crucial QuestionsOctober 2nd, 2019
Barrientos Highlights Emerging Novel Therapies in the CLL PipelineMay 10th, 2019- Join now to see all
Hospital Affiliations
Long Island Jewish Medical CenterNew Hyde Park, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
